<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">Oesophageal cancer</z:e> associated with the <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant condition</z:e> <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> has increased in incidence over the last few years </plain></SENT>
<SENT sid="1" pm="."><plain>Phase II detoxifying enzymes, including <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferases (GSTs) protect the mucosa from carcinogens, which can cause oxidative damage to cells </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, a reduction in these anti-oxidant enzymes can increase the risk of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to compare the extent of GST expression in <z:mpath ids='MPATH_458'>normal</z:mpath> oesophageal tissue, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>DESIGN: Antibodies raised against GST alpha, GST mu, GST <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> and microsomal GST were used to identify expression of these proteins in tissue sections </plain></SENT>
<SENT sid="5" pm="."><plain>METHOD: Paraffin-embedded sections were stained using standard immunohistochemical techniques to demonstrate the pattern of expression of GST proteins in biopsy specimens </plain></SENT>
<SENT sid="6" pm="."><plain>Twelve sections of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> and an equal number of specimens from <z:mpath ids='MPATH_458'>normal</z:mpath> oesophageal tissue were examined, together with sections from <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and <z:mpath ids='MPATH_458'>normal</z:mpath> gastric mucosa </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Expression of the GST enzymes appeared to be reduced in Barrett's tissue compared to <z:mpath ids='MPATH_458'>normal</z:mpath> oesophageal tissue </plain></SENT>
<SENT sid="8" pm="."><plain>Nuclear staining featured in some of the <z:mpath ids='MPATH_458'>normal</z:mpath> tissue sections, but not in Barrett's tissue </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The reduction in GST expression suggested in Barrett's tissue is an interesting finding, as it is possible that reduced expression of these detoxifying enzymes may contribute to the risk of development of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in Barrett's mucosa </plain></SENT>
</text></document>